New immunotherapy for leukemia shows promise in small clinical trial

Posted by on September 21, 2016 6:53 pm
Categories: health

‘Training’ immune cells boosts effectiveness in patients with acute myeloid leukemia (AML), report scientists. A small clinical trial provides evidence that the immune system’s “natural killer” cells can be dialed up in the laboratory, trained to recall that activation and then effectively unleashed to destroy cancer cells in some patients.

Leave a Reply

Your email address will not be published. Required fields are marked *